SlideShare a Scribd company logo
Biopharmaceutical
Factors affecting
Metabolism
-Sajan Maharjan
M.Pharm (1st Sem.)

18/02/2014

1
drug gets into bloodstream

gets to site of action

is “changed” so that it can be excreted

leaves the body

Definition
Drug metabolism is a biochemical modification of
pharmaceutical substances usually through specialized enzymatic
activity.
18/02/2014

2
Metabolite A
Inactive

Enz. A

Enz. B

Metabolite B
Active

Enz. C

Metabolite C
Toxic

Drug

Enz. D

Metabolite D
Undetectable

18/02/2014

3
Mechanism
Drugs

Highly lipophilic

lipophilic

Polar

Hydrophilic

Accumulation
(Storage in body tissues
Phase-1 Metabolism
(Bioactivation or Inactivation)

Polar

Phase-II Metabolism
(Inactivation)

Hydrophilic

18/02/2014

Execretion
(Renal or biliary)

4
Factors affecting Drug Metabolism

Chemical Factors

Biological Factors

Enzyme induction

Age

Enzyme inhibition

Physicochemical
properties of drug

Diet
Sex differences
Species differences
Strain differences
Altered Physiological factors

18/02/2014

5
Chemical Factors
Enzyme induction
It is the phenomenon of incresed drug metabolising ability of
enzymes by several drugs and chemicals.
Consequences
Active
Metabolites

Inactive
Metabolites

Increased
pharmacological
activity or TOXICITY

Decreased
pharmacological
activity
18/02/2014

Altered
physiological
status due to
enhanced
metabolism of
compounds
Eg: sex
hormones

6
Examples of enzyme induction
Oral
Contraceptive
Steroids

CYP3A4

Inactive, Excreted

Induction
Rifampin

Acetaminophen

CYP2E1

p-Quinone Imine (Toxic)

Induction
Ethanol

18/02/2014

7
Enzyme inhibition
It is a decrease in the drug metabolising activity of an enzyme.
The process of inhibition may be:
Direct inhibition

Indirect inhibition

Repression
Decrease in
the enzyme
content

Competitive
inhibition

Altered physiology
Due to nutritional
deficiency or
hormonal
imbalance

Non-competitive
inhibition

18/02/2014

8
Examples of enzyme inhibition
Terfenadine

CYP3A4

Active Antihistamine

Inhibition
Erythromycin
Ketoconazole

Consequences of Inhibition

• Increase in the plasma concentration of parent drug
• Reduction in metabolite concentration
• Exaggerated and prolonged pharmacological effects
• Increased likelihood of drug-induced toxicity
Enzyme inhibition is more important clinically than enzyme
induction esp. for drugs with narrow therapeutic index.
Eg: anticoagulants,antiepileptics,hypoglycemias,etc.
18/02/2014

9
Biological factors
Age

Neonates and infants
(upto 1 year)

Microsomal
enzyme system is
not fully
developed
Many drugs metabolised
slowly
Half life of caffeine
In neonates: 4 days
In adults: 4 hours

Children (1 to 12 years)

Elderly
Reduced
liver size

Rate of
metabolism
reaches maximum
Require large mg/kg
dose than adults
Half life of theophylline
in children is 2/3rd of that
in adults

18/02/2014

Reduced
hepatic
blood flow

Reduced
enzyme
activity

Decreased metabolism
of drugs

10
Diet
Enzyme content and activity is altered by dietary components

Protein diet

Fat free diet

grapefruit

Vitamins and minerals
Vitamin A, B2,B3,C & E

Enzyme
synthesis is
promoted

Increased drug
metabolising
activity

Depresses
cytochrome
P-450 levels

Decreased drug
metabolising
activity

Inhibit
metabolism
of some
drugs
Eg:
Terfenadine

18/02/2014

Ca, Fe, Mg & ZN

Retard metabolic
activity of enzymes

11
Sex difference
 Responsiveness to certain drugs is different for men and women.
 Such variations are generally observed following puberty. So,
sex related differences in the rate of metabolism could probably
be due to sex hormones.
Examples
Studies in animals

Male rats
have greater
drug
metabolising
capacity

Studies in humans

Women metabolise
benzodiazepines
slowly than men

18/02/2014

Women on
contraceptive
pills metabolise
some drugs
slowly
12
Species differences
Differences are mainly quantitative but there are some qualitative
differences too
Examples
In Phase-I reactions

In Phase-II reactions

Metabolism of
amphetamine and
ephedrine

By aromatic
oxidation

By oxidative
deamination

• Variations are mainly qualitative.
Glucuronide conjugation is an
important route of metabolism in
mammals, birds, reptiles, and
amphibians, but not in fish.
In mammals, cats lack the ability to
conjugate phenols with Glucuronic
acid but it dominates in pigs

18/02/2014

13
Strain differences
Pharmacogenetics
(Study of intersubject variability in
drug response)

Ethnic variations
(variation among different races)
Acetylation
of isoniazid

Metabolism of
phenylbutazone,
antipyrine

Whites and blacks
In monozygotic twins

Very little
or No
difference

In dizygotic twins

Large
difference

Equal percent
of slow and
rapid
acetylators
found
18/02/2014

Japanese and Eskimo

Slow
acetylators
dominate

14
Altered Physiological factors

Pregnancy
High levels
of steroid
hormones

Maternal drug
metabolising
ability is reduced

Diseased states
Liver disease
(hepatitis,
jaundice etc)

Reduction in
hepatic drug
metabolising
ability

18/02/2014

Renal
disease

Oxidation of
Vit.D.
Conjugation
of salicylates
are impaired

CCF,
MI

Decrease in
blood flow
to liver

15
Physicochemical properties of drug
Molecular
size and
shape

pKa

Acidity/
Basicity

lipophilicity

Steric and
electronic
characters

Interaction with the active site of
enzyme

Affects metabolic
process
Such an interrelationship is not clearly understood
18/02/2014

16
18/02/2014

17

More Related Content

What's hot

Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
Naresh Gorantla
 
Physicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of DrugsPhysicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of Drugs
Suraj Choudhary
 
MECHANISMS OF DRUG ABSORPTION
MECHANISMS OF DRUG  ABSORPTIONMECHANISMS OF DRUG  ABSORPTION
MECHANISMS OF DRUG ABSORPTION
Dr. SHUBHRAJIT MANTRY
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
Dr.K.Umasankar Krishnamaraju
 
Drug metabolism Phase I Reaction
Drug metabolism Phase I ReactionDrug metabolism Phase I Reaction
Drug metabolism Phase I Reaction
DrParthiban1
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
chiranjibi68
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
Dibrugarh University
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
Malay Pandya
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
Sujit Patel
 
Prodrugs - concept & Applications
Prodrugs - concept & ApplicationsProdrugs - concept & Applications
Prodrugs - concept & Applications
Janet Thomas
 
Introduction to biopharmaceutics
Introduction to biopharmaceuticsIntroduction to biopharmaceutics
Introduction to biopharmaceutics
Suvarta Maru
 
Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugs
Debasish Ghadei
 
Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
pratiksha Pratiksha
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
SURYAKANTVERMA2
 
Non compartment model
Non compartment modelNon compartment model
Non compartment model
VandanaGupta127
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
PRASHANT DEORE
 

What's hot (20)

Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Physicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of DrugsPhysicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of Drugs
 
MECHANISMS OF DRUG ABSORPTION
MECHANISMS OF DRUG  ABSORPTIONMECHANISMS OF DRUG  ABSORPTION
MECHANISMS OF DRUG ABSORPTION
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Drug metabolism Phase I Reaction
Drug metabolism Phase I ReactionDrug metabolism Phase I Reaction
Drug metabolism Phase I Reaction
 
Factors affecting protein drug binding and its kinetics
Factors affecting protein drug binding and its kineticsFactors affecting protein drug binding and its kinetics
Factors affecting protein drug binding and its kinetics
 
Factors affecting metabolism
Factors affecting metabolismFactors affecting metabolism
Factors affecting metabolism
 
Concept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretionConcept of clearance & factors affecting renal excretion
Concept of clearance & factors affecting renal excretion
 
Nonlinear Pharmacokinetics
Nonlinear PharmacokineticsNonlinear Pharmacokinetics
Nonlinear Pharmacokinetics
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Drug absorption
Drug absorption Drug absorption
Drug absorption
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
Prodrugs - concept & Applications
Prodrugs - concept & ApplicationsProdrugs - concept & Applications
Prodrugs - concept & Applications
 
Introduction to biopharmaceutics
Introduction to biopharmaceuticsIntroduction to biopharmaceutics
Introduction to biopharmaceutics
 
Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugs
 
Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Non compartment model
Non compartment modelNon compartment model
Non compartment model
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
 

Similar to Biopharmaceutical factors affecting metabolism

Factors affecting biotransformation of drugs
Factors affecting biotransformation of drugsFactors affecting biotransformation of drugs
Factors affecting biotransformation of drugsvincyv88
 
Factors affecting metabolism of drug
Factors affecting metabolism of drugFactors affecting metabolism of drug
Factors affecting metabolism of drug
Nilesh Kulkarni
 
Priyanka biotransformation
Priyanka  biotransformationPriyanka  biotransformation
Priyanka biotransformationpriya0900
 
Drug metabolism affected by diseases
Drug metabolism affected by diseasesDrug metabolism affected by diseases
Drug metabolism affected by diseases
azamushahiullah prottoy
 
Factors affecting drug metabolism
Factors affecting drug metabolismFactors affecting drug metabolism
Factors affecting drug metabolism
Asha Suryawanshi
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
BDslidembstu
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolism
M.Arumuga Vignesh
 
Factors affecting biotransformation
Factors affecting biotransformationFactors affecting biotransformation
Factors affecting biotransformation
Muhammad Usama
 
Factors affecting biotransformation of drugs
Factors affecting biotransformation of drugsFactors affecting biotransformation of drugs
Factors affecting biotransformation of drugsZubia Arshad
 
BIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptx
BIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptxBIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptx
BIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptx
PHARMA IQ EDUCATION
 
Pharmacokinetics variations in Disease States.
Pharmacokinetics variations in Disease States.Pharmacokinetics variations in Disease States.
Pharmacokinetics variations in Disease States.
Faizan Akram
 
Dr. Obumneke Amadi-Onuoha - 15_ fctr
Dr. Obumneke Amadi-Onuoha - 15_ fctrDr. Obumneke Amadi-Onuoha - 15_ fctr
Dr. Obumneke Amadi-Onuoha - 15_ fctr
Discover Health Global Initiative
 
Biotrasformation by S.Pathak.pptx
Biotrasformation by S.Pathak.pptxBiotrasformation by S.Pathak.pptx
Biotrasformation by S.Pathak.pptx
Sachchidanand Pathak
 
5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx
bilaliqbal02
 
Metabolism I
Metabolism IMetabolism I
Metabolism I
Kailas Mali
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolism
SwarnaPriyaBasker
 
Metabolism,Excretion,prodrug,Therapeutic Drug monitoring
Metabolism,Excretion,prodrug,Therapeutic Drug monitoringMetabolism,Excretion,prodrug,Therapeutic Drug monitoring
Metabolism,Excretion,prodrug,Therapeutic Drug monitoring
SrinivasSree11
 
19. genetic-polymorphism-in-drug-metabolism seminar.pptx
19. genetic-polymorphism-in-drug-metabolism  seminar.pptx19. genetic-polymorphism-in-drug-metabolism  seminar.pptx
19. genetic-polymorphism-in-drug-metabolism seminar.pptx
KiranChoudhari6
 
Biotransformation_of_drug[ and contraindications of the 2].pptx
Biotransformation_of_drug[ and contraindications of the 2].pptxBiotransformation_of_drug[ and contraindications of the 2].pptx
Biotransformation_of_drug[ and contraindications of the 2].pptx
fakeloginn69
 
Nz pep lecture_jan2016
Nz pep lecture_jan2016Nz pep lecture_jan2016
Nz pep lecture_jan2016
Pharmacology Education Project
 

Similar to Biopharmaceutical factors affecting metabolism (20)

Factors affecting biotransformation of drugs
Factors affecting biotransformation of drugsFactors affecting biotransformation of drugs
Factors affecting biotransformation of drugs
 
Factors affecting metabolism of drug
Factors affecting metabolism of drugFactors affecting metabolism of drug
Factors affecting metabolism of drug
 
Priyanka biotransformation
Priyanka  biotransformationPriyanka  biotransformation
Priyanka biotransformation
 
Drug metabolism affected by diseases
Drug metabolism affected by diseasesDrug metabolism affected by diseases
Drug metabolism affected by diseases
 
Factors affecting drug metabolism
Factors affecting drug metabolismFactors affecting drug metabolism
Factors affecting drug metabolism
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolism
 
Factors affecting biotransformation
Factors affecting biotransformationFactors affecting biotransformation
Factors affecting biotransformation
 
Factors affecting biotransformation of drugs
Factors affecting biotransformation of drugsFactors affecting biotransformation of drugs
Factors affecting biotransformation of drugs
 
BIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptx
BIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptxBIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptx
BIOTRANSFORMATION UNIT -1 DRUG METABOLISM (1).pptx
 
Pharmacokinetics variations in Disease States.
Pharmacokinetics variations in Disease States.Pharmacokinetics variations in Disease States.
Pharmacokinetics variations in Disease States.
 
Dr. Obumneke Amadi-Onuoha - 15_ fctr
Dr. Obumneke Amadi-Onuoha - 15_ fctrDr. Obumneke Amadi-Onuoha - 15_ fctr
Dr. Obumneke Amadi-Onuoha - 15_ fctr
 
Biotrasformation by S.Pathak.pptx
Biotrasformation by S.Pathak.pptxBiotrasformation by S.Pathak.pptx
Biotrasformation by S.Pathak.pptx
 
5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx5-Biotransformation and metabolism .pptx
5-Biotransformation and metabolism .pptx
 
Metabolism I
Metabolism IMetabolism I
Metabolism I
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolism
 
Metabolism,Excretion,prodrug,Therapeutic Drug monitoring
Metabolism,Excretion,prodrug,Therapeutic Drug monitoringMetabolism,Excretion,prodrug,Therapeutic Drug monitoring
Metabolism,Excretion,prodrug,Therapeutic Drug monitoring
 
19. genetic-polymorphism-in-drug-metabolism seminar.pptx
19. genetic-polymorphism-in-drug-metabolism  seminar.pptx19. genetic-polymorphism-in-drug-metabolism  seminar.pptx
19. genetic-polymorphism-in-drug-metabolism seminar.pptx
 
Biotransformation_of_drug[ and contraindications of the 2].pptx
Biotransformation_of_drug[ and contraindications of the 2].pptxBiotransformation_of_drug[ and contraindications of the 2].pptx
Biotransformation_of_drug[ and contraindications of the 2].pptx
 
Nz pep lecture_jan2016
Nz pep lecture_jan2016Nz pep lecture_jan2016
Nz pep lecture_jan2016
 

More from SR drug laboratories

Recent advances in hplc and gc
Recent advances in hplc and gcRecent advances in hplc and gc
Recent advances in hplc and gc
SR drug laboratories
 
Liquid dosage form monophsaic
Liquid dosage form monophsaicLiquid dosage form monophsaic
Liquid dosage form monophsaic
SR drug laboratories
 
National drug policy of Nepal
National drug policy of NepalNational drug policy of Nepal
National drug policy of Nepal
SR drug laboratories
 
Medicines registration & licensing of pharmaceutical establishments of Nepal
Medicines registration  & licensing of pharmaceutical establishments of NepalMedicines registration  & licensing of pharmaceutical establishments of Nepal
Medicines registration & licensing of pharmaceutical establishments of Nepal
SR drug laboratories
 
Pharmaceutical policy of Nepal
Pharmaceutical policy of NepalPharmaceutical policy of Nepal
Pharmaceutical policy of Nepal
SR drug laboratories
 
Standards institutions of Nepal
Standards institutions of NepalStandards institutions of Nepal
Standards institutions of Nepal
SR drug laboratories
 
mathematical models for drug release studies
mathematical models for drug release studiesmathematical models for drug release studies
mathematical models for drug release studies
SR drug laboratories
 
Absorption
AbsorptionAbsorption
Biodegradable natural polymers (2)
Biodegradable natural polymers (2)Biodegradable natural polymers (2)
Biodegradable natural polymers (2)SR drug laboratories
 

More from SR drug laboratories (10)

Recent advances in hplc and gc
Recent advances in hplc and gcRecent advances in hplc and gc
Recent advances in hplc and gc
 
Liquid dosage form monophsaic
Liquid dosage form monophsaicLiquid dosage form monophsaic
Liquid dosage form monophsaic
 
National drug policy of Nepal
National drug policy of NepalNational drug policy of Nepal
National drug policy of Nepal
 
Medicines registration & licensing of pharmaceutical establishments of Nepal
Medicines registration  & licensing of pharmaceutical establishments of NepalMedicines registration  & licensing of pharmaceutical establishments of Nepal
Medicines registration & licensing of pharmaceutical establishments of Nepal
 
Pharmaceutical policy of Nepal
Pharmaceutical policy of NepalPharmaceutical policy of Nepal
Pharmaceutical policy of Nepal
 
Standards institutions of Nepal
Standards institutions of NepalStandards institutions of Nepal
Standards institutions of Nepal
 
mathematical models for drug release studies
mathematical models for drug release studiesmathematical models for drug release studies
mathematical models for drug release studies
 
Absorption
AbsorptionAbsorption
Absorption
 
Biodegradable natural polymers (2)
Biodegradable natural polymers (2)Biodegradable natural polymers (2)
Biodegradable natural polymers (2)
 
QRM sustained release
QRM sustained releaseQRM sustained release
QRM sustained release
 

Recently uploaded

678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 

Recently uploaded (20)

678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 

Biopharmaceutical factors affecting metabolism

  • 2. drug gets into bloodstream gets to site of action is “changed” so that it can be excreted leaves the body Definition Drug metabolism is a biochemical modification of pharmaceutical substances usually through specialized enzymatic activity. 18/02/2014 2
  • 3. Metabolite A Inactive Enz. A Enz. B Metabolite B Active Enz. C Metabolite C Toxic Drug Enz. D Metabolite D Undetectable 18/02/2014 3
  • 4. Mechanism Drugs Highly lipophilic lipophilic Polar Hydrophilic Accumulation (Storage in body tissues Phase-1 Metabolism (Bioactivation or Inactivation) Polar Phase-II Metabolism (Inactivation) Hydrophilic 18/02/2014 Execretion (Renal or biliary) 4
  • 5. Factors affecting Drug Metabolism Chemical Factors Biological Factors Enzyme induction Age Enzyme inhibition Physicochemical properties of drug Diet Sex differences Species differences Strain differences Altered Physiological factors 18/02/2014 5
  • 6. Chemical Factors Enzyme induction It is the phenomenon of incresed drug metabolising ability of enzymes by several drugs and chemicals. Consequences Active Metabolites Inactive Metabolites Increased pharmacological activity or TOXICITY Decreased pharmacological activity 18/02/2014 Altered physiological status due to enhanced metabolism of compounds Eg: sex hormones 6
  • 7. Examples of enzyme induction Oral Contraceptive Steroids CYP3A4 Inactive, Excreted Induction Rifampin Acetaminophen CYP2E1 p-Quinone Imine (Toxic) Induction Ethanol 18/02/2014 7
  • 8. Enzyme inhibition It is a decrease in the drug metabolising activity of an enzyme. The process of inhibition may be: Direct inhibition Indirect inhibition Repression Decrease in the enzyme content Competitive inhibition Altered physiology Due to nutritional deficiency or hormonal imbalance Non-competitive inhibition 18/02/2014 8
  • 9. Examples of enzyme inhibition Terfenadine CYP3A4 Active Antihistamine Inhibition Erythromycin Ketoconazole Consequences of Inhibition • Increase in the plasma concentration of parent drug • Reduction in metabolite concentration • Exaggerated and prolonged pharmacological effects • Increased likelihood of drug-induced toxicity Enzyme inhibition is more important clinically than enzyme induction esp. for drugs with narrow therapeutic index. Eg: anticoagulants,antiepileptics,hypoglycemias,etc. 18/02/2014 9
  • 10. Biological factors Age Neonates and infants (upto 1 year) Microsomal enzyme system is not fully developed Many drugs metabolised slowly Half life of caffeine In neonates: 4 days In adults: 4 hours Children (1 to 12 years) Elderly Reduced liver size Rate of metabolism reaches maximum Require large mg/kg dose than adults Half life of theophylline in children is 2/3rd of that in adults 18/02/2014 Reduced hepatic blood flow Reduced enzyme activity Decreased metabolism of drugs 10
  • 11. Diet Enzyme content and activity is altered by dietary components Protein diet Fat free diet grapefruit Vitamins and minerals Vitamin A, B2,B3,C & E Enzyme synthesis is promoted Increased drug metabolising activity Depresses cytochrome P-450 levels Decreased drug metabolising activity Inhibit metabolism of some drugs Eg: Terfenadine 18/02/2014 Ca, Fe, Mg & ZN Retard metabolic activity of enzymes 11
  • 12. Sex difference  Responsiveness to certain drugs is different for men and women.  Such variations are generally observed following puberty. So, sex related differences in the rate of metabolism could probably be due to sex hormones. Examples Studies in animals Male rats have greater drug metabolising capacity Studies in humans Women metabolise benzodiazepines slowly than men 18/02/2014 Women on contraceptive pills metabolise some drugs slowly 12
  • 13. Species differences Differences are mainly quantitative but there are some qualitative differences too Examples In Phase-I reactions In Phase-II reactions Metabolism of amphetamine and ephedrine By aromatic oxidation By oxidative deamination • Variations are mainly qualitative. Glucuronide conjugation is an important route of metabolism in mammals, birds, reptiles, and amphibians, but not in fish. In mammals, cats lack the ability to conjugate phenols with Glucuronic acid but it dominates in pigs 18/02/2014 13
  • 14. Strain differences Pharmacogenetics (Study of intersubject variability in drug response) Ethnic variations (variation among different races) Acetylation of isoniazid Metabolism of phenylbutazone, antipyrine Whites and blacks In monozygotic twins Very little or No difference In dizygotic twins Large difference Equal percent of slow and rapid acetylators found 18/02/2014 Japanese and Eskimo Slow acetylators dominate 14
  • 15. Altered Physiological factors Pregnancy High levels of steroid hormones Maternal drug metabolising ability is reduced Diseased states Liver disease (hepatitis, jaundice etc) Reduction in hepatic drug metabolising ability 18/02/2014 Renal disease Oxidation of Vit.D. Conjugation of salicylates are impaired CCF, MI Decrease in blood flow to liver 15
  • 16. Physicochemical properties of drug Molecular size and shape pKa Acidity/ Basicity lipophilicity Steric and electronic characters Interaction with the active site of enzyme Affects metabolic process Such an interrelationship is not clearly understood 18/02/2014 16